2025年12月

When it comes to rare genetic disorders, Laron Syndrome stands out as both a medical puzzle and a testament to the challenges facing ultra-rare disease markets. This exceptionally uncommon growth disorder affects only a handful of people per million world ... もっと読む

Healthcare innovation is taking an exciting turn with the development of OX40 ligand inhibitors, a breakthrough class of therapies showing real promise for patients struggling with inflammatory and autoimmune disorders. The OX40 Ligand Inhibitors Market ... もっと読む

Human papillomavirus research has traditionally centered on cervical and throat cancers, yet a growing body of evidence reveals its significant role in skin malignancies. Beta-HPV strains have been implicated in various cutaneous tumors, particularly affe ... もっと読む

ObjectiveDelveInsight was engaged by a leading U.S.-based pharmaceutical company with expertise in drug delivery devices to conduct a comprehensive assessment of the dissolvable microneedle technology (dMTS) landscape. The primary objective was to identif ... もっと読む

ObjectiveDelveInsight was engaged by a mid-sized pharmaceutical company headquartered in the United States to provide a comprehensive Go-To-Market (GTM) strategy assessment for their biosimilar portfolio in Europe. The client sought detailed insights into ... もっと読む

↑このページのトップヘ